Key result
Long-term treatment with the androgen-receptor antagonist flutamide markedly reduced the expression of ryanodine receptors and their contribution to Ca2+ release and contraction in rat vas deferens.
Why the study?
Does flutamide reduce ryanodine receptor-mediated Ca2+ release and expression in vas deferens smooth muscle cells in male rats?
Does flutamide reduce ryanodine receptor-mediated Ca2+ release and expression in vas deferens smooth muscle cells in male rats?
Long-term androgen receptor blockade by flutamide reduces the expression of ryanodine receptors and their contribution to contraction in vas deferens smooth muscle cells.
Answers are grounded in this paper and cite their sources.
Flutamide alters Ca2+ handling in rat vas deferens; hypothesis-generating for androgen effects on human smooth muscle, with no clinical implications yet.
Ca(2+) release from intracellular store sites via the ryanodine receptor (RyR) and hormonal regulation by flutamide, an androgen-receptor (AR) antagonist, on it were examined in vas deferens (VD) smooth muscle cells (SMCs). VD and VDSMCs were obtained from two groups of male rats that were treated p.o. with 100 mg/kg flutamide (Flu) or vehicle (Vehicle). Both spontaneous and caffeine-induced Ca(2+) releases were markedly smaller in single VDSMCs from Flu than in those from Vehicle. Interestingly, [Ca(2+)](i) rise by 100 muM norepinephrine in VDSMCs from Flu was larger than that in those from Vehicle. The contractions induced by direct electrical stimulation in tissue preparations from Flu showed lower susceptibility to 30 muM ryanodine than those from Vehicle. Real-time PCR analyses revealed that the transcripts of ryanodine receptor (RyR) type 2 and type 3 (RyR2 and RyR3) were expressed in VD and markedly reduced in Flu. The protein expression of total RyR was significantly reduced by flutamide treatment, but that of inositol 1,4,5-trisphosphate receptor (IP3R) was not affected. It can be strongly suggested that long term block of AR by flutamide reduced the expression of RyR and its contribution to the contraction, but not those of IP3R in VDSMCs.
No takes yet. Share an insight, caveat, or question.
Ohno et al. (2009) studied Healthy. Flutamide vs. Vehicle was evaluated on Peak Ca2+ rise (Δratio) in response to 30 mM caffeine in vas deferens smooth muscle cells (p=<0.01). Long-term treatment with the androgen-receptor antagonist flutamide markedly reduced the expression of ryanodine receptors and their contribution to Ca2+ release and contraction in rat vas deferens.
Synapse has enriched 10 related papers. Consider them for comparative context: